Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer SurvivalJuan José Lahuerta, Jesús F. San Miguel, María‐Victoria Mateos et al.|Journal of Clinical Oncology|2008Cited by 282
Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 studyJuan José Lahuerta, M.V. Mateos, Joaquín Martínez‐López et al.|Haematologica|2010Cited by 113
Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluidRicardo Sánchez, Joaquín Martínez‐López, Santiago Mercadal et al.|Annals of Hematology|2017Cited by 30
Optical Genome Mapping ( <scp>OGM</scp> ): Validation and Clinical Utility in the Cytogenetic Diagnosis of Multiple MyelomaAdela Cisneros, Isabel Granada, Mar Mallo et al.|American Journal of Hematology|2025Cited by 1